Lv3
220 积分 2025-11-09 加入
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
11天前
已完结
治疗KRAS G12C突变非小细胞肺癌新药——Adagrasib
19天前
已完结
Adagrasib: A landmark in the KRASG12C‐mutated NSCLC
19天前
已完结
Adagrasib in Non–Small-Cell Lung Cancer
19天前
已完结
Adagrasib: a novel inhibitor for KRAS G12C -mutated non-small-cell lung cancer
19天前
已完结
First Approval of Adagrasib for the Treatment of Non-Small CellLung Cancer Harboring a KRASG12C Mutation
19天前
已完结
Absorption, single-dose and steady-state metabolism, excretion, and pharmacokinetics of adagrasib, a KRASG12C inhibitor
19天前
已完结
A Comprehensive Development and Validation of a Stability‐Indicating High‐Performance Liquid Chromatographic Method for Adagrasib Drug Substance With Degradation Product Characterization by Liquid Chromatography‐Tandem Mass Spectrophotometry
19天前
已完结
治疗KRAS G12C突变非小细胞肺癌新药Adagrasib的临床评价
19天前
已完结
皖公网安备34019202002308
